Stock-Based Compensation (Tables)

9 Months Ended

Oct. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based compensation expense by type of grant

	Three Months Ended						Nine Months Ended
	October 31, 2015			November 1, 2014			October 31, 2015			November 1, 2014
Stock options and stock appreciation rights ("SARs")	$	—		$	184		$	30		$	521
Non-vested stock	1,719			1,294			5,133			3,690
Performance shares	1,278			1,104			3,763			2,807
Total compensation expense	2,997			2,582			8,926			7,018
Related tax benefit	(1,126		)	(971		)	(3,356		)	(2,639		)
Stock-based compensation expense, net of tax	$	1,871		$	1,611		$	5,570		$	4,379

Stock options and Stock appreciation rights outstanding

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding at January 31, 2015	418,525		$	16.49
Exercised	(160,650	)	15.32
Forfeited	(25,725	)	18.01
Outstanding, vested and exercisable at October 31, 2015	232,150		$	17.13	1.9	$	—

Nonvested stock options and Stock appreciation rights outstanding

Stock Options/SARs	Number of Shares		Weighted Average Grant  Date Fair Value
Non-vested at January 31, 2015	69,763		$	8.69
Vested	(69,763	)	8.69
Non-vested at October 31, 2015	—		$	—

Non-vested stock granted

Non-vested Stock	Number of Shares		Weighted Average Grant  Date Fair Value
Outstanding at January 31, 2015	678,604		$	21.76
Granted	474,728		20.65
Vested	(264,402	)	20.75
Forfeited	(38,768	)	22.10
Outstanding at October 31, 2015	850,162		$	21.44

Performance shares outstanding

Period Granted	Target Shares Outstanding at January 31, 2015	Target Shares Granted	Target Shares Vested	Target Shares Forfeited		Target Shares Outstanding at October 31, 2015	Weighted Average Grant Date Fair Value Per Share
2013	118,250	—	—	(2,200	)	116,050	$	33.81
2014	166,153	—	—	(2,292	)	163,861	33.84
2015	—	227,685	—	(3,809	)	223,876	28.33
Total	284,403	227,685	—	(8,301	)	503,787